OLMESARTAN HCT ASTRON (Accord Healthcare Pty Ltd)
Product name
OLMESARTAN HCT ASTRON
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
181 (255 working days)
Active ingredients
Hydrochlorothiazide, Olmesartan medoxomil
Registration type
New generic medicine
Indication
Treatment of hypertension.
Treatment should not be initiated with this fixed dose combination.